304 related articles for article (PubMed ID: 15156175)
21. RUNX1 transformation of primary embryonic fibroblasts is revealed in the absence of p53.
Wotton SF; Blyth K; Kilbey A; Jenkins A; Terry A; Bernardin-Fried F; Friedman AD; Baxter EW; Neil JC; Cameron ER
Oncogene; 2004 Jul; 23(32):5476-86. PubMed ID: 15133495
[TBL] [Abstract][Full Text] [Related]
22. Dual functions of Runx proteins for reactivating CD8 and silencing CD4 at the commitment process into CD8 thymocytes.
Sato T; Ohno S; Hayashi T; Sato C; Kohu K; Satake M; Habu S
Immunity; 2005 Mar; 22(3):317-28. PubMed ID: 15780989
[TBL] [Abstract][Full Text] [Related]
23. RUNX and cancer.
Ito Y; Osato M; Ito K
Ann Acad Med Singap; 2003 Sep; 32(5 Suppl):S6-7. PubMed ID: 14968716
[No Abstract] [Full Text] [Related]
24. HOX cofactors expression and regulation in the human ovary.
Ota T; Asahina H; Park SH; Huang Q; Minegishi T; Auersperg N; Leung PC
Reprod Biol Endocrinol; 2008 Oct; 6():49. PubMed ID: 18973687
[TBL] [Abstract][Full Text] [Related]
25. Antagonistic interplay between ThPOK and Runx in lineage choice of thymocytes.
Egawa T; Taniuchi I
Blood Cells Mol Dis; 2009; 43(1):27-9. PubMed ID: 19375362
[TBL] [Abstract][Full Text] [Related]
26. Expression of AML/Runx and ETO/MTG family members during hematopoietic differentiation of embryonic stem cells.
Okumura AJ; Peterson LF; Lo MC; Zhang DE
Exp Hematol; 2007 Jun; 35(6):978-88. PubMed ID: 17533052
[TBL] [Abstract][Full Text] [Related]
27. AML-1 steps up to the platelets.
Irvin BJ; Hiebert SW
Nat Med; 2004 Mar; 10(3):238-9. PubMed ID: 14991045
[No Abstract] [Full Text] [Related]
28. Dexamethasone inhibits insulin-induced chondrogenesis of ATDC5 cells by preventing PI3K-Akt signaling and DNA binding of Runx2.
Fujita T; Fukuyama R; Enomoto H; Komori T
J Cell Biochem; 2004 Oct; 93(2):374-83. PubMed ID: 15368363
[TBL] [Abstract][Full Text] [Related]
29. Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia.
Osato M
Oncogene; 2004 May; 23(24):4284-96. PubMed ID: 15156185
[TBL] [Abstract][Full Text] [Related]
30. Multilineage transcriptional priming and determination of alternate hematopoietic cell fates.
Laslo P; Spooner CJ; Warmflash A; Lancki DW; Lee HJ; Sciammas R; Gantner BN; Dinner AR; Singh H
Cell; 2006 Aug; 126(4):755-66. PubMed ID: 16923394
[TBL] [Abstract][Full Text] [Related]
31. Pre-B-cell leukemia transcription factor 1 is a major target of promyelocytic leukemia zinc-finger-mediated melanoma cell growth suppression.
Shiraishi K; Yamasaki K; Nanba D; Inoue H; Hanakawa Y; Shirakata Y; Hashimoto K; Higashiyama S
Oncogene; 2007 Jan; 26(3):339-48. PubMed ID: 16862184
[TBL] [Abstract][Full Text] [Related]
32. The evolution of Runx genes I. A comparative study of sequences from phylogenetically diverse model organisms.
Rennert J; Coffman JA; Mushegian AR; Robertson AJ
BMC Evol Biol; 2003 Mar; 3():4. PubMed ID: 12659662
[TBL] [Abstract][Full Text] [Related]
33. Runx proteins are involved in regulation of CD122, Ly49 family and IFN-gamma expression during NK cell differentiation.
Ohno S; Sato T; Kohu K; Takeda K; Okumura K; Satake M; Habu S
Int Immunol; 2008 Jan; 20(1):71-9. PubMed ID: 18003603
[TBL] [Abstract][Full Text] [Related]
34. Nuclear microenvironments: an architectural platform for the convergence and integration of transcriptional regulatory signals.
Stein GS; Stein JL; Lian JB; Van Wijnen AJ; Montecino M; Javed A; Zaidi SK; Young D; Choi JY; Pockwinse S
Eur J Histochem; 2004; 48(1):65-76. PubMed ID: 15145777
[TBL] [Abstract][Full Text] [Related]
35. Runx3-deficient mouse strains circa 2008: resemblance and dissimilarity.
Levanon D; Groner Y
Blood Cells Mol Dis; 2009; 43(1):1-5. PubMed ID: 19233693
[TBL] [Abstract][Full Text] [Related]
36. Role of RUNX in autoimmune diseases linking rheumatoid arthritis, psoriasis and lupus.
Alarcón-Riquelme ME
Arthritis Res Ther; 2004; 6(4):169-73. PubMed ID: 15225361
[TBL] [Abstract][Full Text] [Related]
37. Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice.
Yanagida M; Osato M; Yamashita N; Liqun H; Jacob B; Wu F; Cao X; Nakamura T; Yokomizo T; Takahashi S; Yamamoto M; Shigesada K; Ito Y
Oncogene; 2005 Jun; 24(28):4477-85. PubMed ID: 15856017
[TBL] [Abstract][Full Text] [Related]
38. Repression of the transcription factor Th-POK by Runx complexes in cytotoxic T cell development.
Setoguchi R; Tachibana M; Naoe Y; Muroi S; Akiyama K; Tezuka C; Okuda T; Taniuchi I
Science; 2008 Feb; 319(5864):822-5. PubMed ID: 18258917
[TBL] [Abstract][Full Text] [Related]
39. The Runx1 transcription factor controls CSF-1-dependent and -independent growth and survival of macrophages.
Himes SR; Cronau S; Mulford C; Hume DA
Oncogene; 2005 Aug; 24(34):5278-86. PubMed ID: 16007221
[TBL] [Abstract][Full Text] [Related]
40. Regulation of gene expression in peripheral T cells by Runx transcription factors.
Djuretic IM; Cruz-Guilloty F; Rao A
Adv Immunol; 2009; 104():1-23. PubMed ID: 20457114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
